FGF17-Mediated Pathways: Targeting FGFR3 and FGFR4 for neuroinflammation and myelination in spinal cord injury

Spinal cord injury affects more than 300,000 people in the United States. A large portion of these injuries are at the cervical level and pose greater challenges to limb and respiratory function. Demyelination and neuroinflammation contribute to secondary injury cascades further impairing recovery. The fibroblast growth factor (FGF) family has shown promise in improving function following spinal cord injury, particularly FGF1 and FGF2. However, FGF1 and FGF2 are implicated in neural regeneration rather than focusing on glia. Though, emerging evidence suggests that other members of the FGF family, including FGF17, may play a significant role in promoting myelination, and reducing neuroinflammation. Despite its potential, the effects of FGF17 on spinal cord injury recovery remain largely unexplored, highlighting the importance of further investigation into its therapeutic applications. FGF17 has a higher affinity for FGF receptors 3 and 4 but there is not much known regarding where they are expressed. Thus, with this project we sought to evaluate the cellular distribution of these receptors and how that expression pattern changes following spinal cord injury. We used a rat C4 contusion injury model and harvested tissue at 7 days post-injury. Tissue was stained for markers of FGFR3, FGFR4, oligodendrocytes (O4), astrocytes (GFAP), and neurons (NeuN), to assess localization and presence of FGF17 receptors as well as the potential effects on myelination and inflammation following spinal cord injury. Data analysis showed increased colocalization of FGFR4 on astrocytes as well as FGFR3 on oligodendrocytes in contused animals. These findings suggest that FGF17 may act on these glial receptors to influence recovery pathways, such as enhancing myelination and reducing inflammation. Future studies leveraging FGF17 could further clarify its therapeutic potential in SCI recovery. Kentucky Spinal Cord & Head Injury Research Trust (WJA), Craig H. Neilsen Foundation Fellowship (MDS), UK Office of Biomedical Education Undergraduate Research Award (CED) This abstract was presented at the American Physiology Summit 2025 and is only available in HTML format. There is no downloadable file or PDF version. The Physiology editorial board was not involved in the peer review process.

Authors

Institutions

Publication Details

Journal
Physiology
Published
2025-05-01
DOI
https://doi.org/10.1152/physiol.2025.40.s1.1038
Primary Topic
Fibroblast Growth Factor Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

FGF17-Mediated Pathways: Targeting FGFR3 and FGFR4 for neuroinflammation and myelination in spinal cord injury

Caroline Devine, Warren J. Alilain, Michael D. Sunshine
Physiology
Fibroblast Growth Factor Research
article

FGF17-Mediated Pathways: Targeting FGFR3 and FGFR4 for neuroinflammation and myelination in spinal cord injury

Caroline Devine, Warren J. Alilain, Michael D. Sunshine
article en

Abstract

Spinal cord injury affects more than 300,000 people in the United States. A large portion of these injuries are at the cervical level and pose greater challenges to limb and respiratory function. Demyelination and neuroinflammation contribute to secondary injury cascades further impairing recovery. The fibroblast growth factor (FGF) family has shown promise in improving function following spinal cord injury, particularly FGF1 and FGF2. However, FGF1 and FGF2 are implicated in neural regeneration rather than focusing on glia. Though, emerging evidence suggests that other members of the FGF family, including FGF17, may play a significant role in promoting myelination, and reducing neuroinflammation. Despite its potential, the effects of FGF17 on spinal cord injury recovery remain largely unexplored, highlighting the importance of further investigation into its therapeutic applications. FGF17 has a higher affinity for FGF receptors 3 and 4 but there is not much known regarding where they are expressed. Thus, with this project we sought to evaluate the cellular distribution of these receptors and how that expression pattern changes following spinal cord injury. We used a rat C4 contusion injury model and harvested tissue at 7 days post-injury. Tissue was stained for markers of FGFR3, FGFR4, oligodendrocytes (O4), astrocytes (GFAP), and neurons (NeuN), to assess localization and presence of FGF17 receptors as well as the potential effects on myelination and inflammation following spinal cord injury. Data analysis showed increased colocalization of FGFR4 on astrocytes as well as FGFR3 on oligodendrocytes in contused animals. These findings suggest that FGF17 may act on these glial receptors to influence recovery pathways, such as enhancing myelination and reducing inflammation. Future studies leveraging FGF17 could further clarify its therapeutic potential in SCI recovery. Kentucky Spinal Cord & Head Injury Research Trust (WJA), Craig H. Neilsen Foundation Fellowship (MDS), UK Office of Biomedical Education Undergraduate Research Award (CED) This abstract was presented at the American Physiology Summit 2025 and is only available in HTML format. There is no downloadable file or PDF version. The Physiology editorial board was not involved in the peer review process.

PhysiologyVol. 40(S1)
University of Kentucky (US)
Openalex Percentile: Top 86%
Fibroblast Growth Factor Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.